Associations Between Cardiovascular Events and Nonergot Dopamine Agonists in Parkinson's Disease

BACKGROUND: Knowledge of possible cardiovascular risks from Parkinson's disease (PD) medications is critical to informing safe and effective treatment decisions. The objective of our study was to determine whether PD patients treated with nonergot dopamine agonists (DAs) are at increased risk o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mov Disord Clin Pract
Main Authors: Crispo, James A.G., Willis, Allison W., Thibault, Dylan P., Fortin, Yannick, Emons, Matthew, Bjerre, Lise M., Kohen, Dafna E., Perez‐Lloret, Santiago, Mattison, Donald, Krewski, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178630/
https://ncbi.nlm.nih.gov/pubmed/30363519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12286
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados